- Home
- PCRX vs KIDS Comparison
PCRX vs KIDS Comparison
Compare PCRX & KIDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- KIDS
- Stock Information
- Founded
- PCRX 2006
- KIDS 2007
- Country
- PCRX United States
- KIDS United States
- Employees
- PCRX N/A
- KIDS N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- KIDS Medical/Dental Instruments
- Sector
- PCRX Health Care
- KIDS Health Care
- Exchange
- PCRX Nasdaq
- KIDS Nasdaq
- Market Cap
- PCRX 1.2B
- KIDS 524.3M
- IPO Year
- PCRX 2011
- KIDS 2017
- Fundamental
- Price
- PCRX $26.51
- KIDS $19.59
- Analyst Decision
- PCRX Buy
- KIDS Strong Buy
- Analyst Count
- PCRX 6
- KIDS 7
- Target Price
- PCRX $30.00
- KIDS $34.14
- AVG Volume (30 Days)
- PCRX 605.6K
- KIDS 128.8K
- Earning Date
- PCRX 11-05-2025
- KIDS 11-05-2025
- Dividend Yield
- PCRX N/A
- KIDS N/A
- EPS Growth
- PCRX N/A
- KIDS N/A
- EPS
- PCRX N/A
- KIDS N/A
- Revenue
- PCRX $705,848,000.00
- KIDS $220,733,000.00
- Revenue This Year
- PCRX $7.36
- KIDS $19.26
- Revenue Next Year
- PCRX $10.07
- KIDS $17.15
- P/E Ratio
- PCRX N/A
- KIDS N/A
- Revenue Growth
- PCRX 2.25
- KIDS 26.08
- 52 Week Low
- PCRX $13.04
- KIDS $16.59
- 52 Week High
- PCRX $27.64
- KIDS $32.93
- Technical
- Relative Strength Index (RSI)
- PCRX 56.74
- KIDS 43.62
- Support Level
- PCRX $26.22
- KIDS $19.30
- Resistance Level
- PCRX $27.50
- KIDS $21.35
- Average True Range (ATR)
- PCRX 0.93
- KIDS 0.84
- MACD
- PCRX -0.09
- KIDS -0.11
- Stochastic Oscillator
- PCRX 43.78
- KIDS 14.19
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.